Proteome Sciences (LON:PRM) Shares Down 2.7% – Should You Sell?

Proteome Sciences plc (LON:PRM) dropped 2.7% on Monday . The stock traded as low as GBX 3.60 ($0.05) and last traded at GBX 3.60 ($0.05). Approximately 1,183,886 shares were traded during trading, an increase of 573% from the average daily volume of 175,815 shares. The stock had previously closed at GBX 3.70 ($0.05).

Proteome Sciences Trading Down 8.6 %

The firm has a market cap of £10.33 million, a P/E ratio of -2.53 and a beta of 0.07. The stock has a 50 day simple moving average of GBX 4.10 and a 200-day simple moving average of GBX 3.43. The company has a current ratio of 0.20, a quick ratio of 0.37 and a debt-to-equity ratio of -258.66.

About Proteome Sciences

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.